1. Home
  2. Live Updates
  3. Oronavirus disease covid 19

Live Breaking News & Updates on Oronavirus disease covid 19

Stay informed with the latest breaking news from Oronavirus disease covid 19 on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Oronavirus disease covid 19 and stay connected to the pulse of your community

SARS-CoV-2-infection and vaccine-induced antibodies wane initially but stabilize for lasting protection

A study published in Immunity shows that antibody responses to SARS-CoV-2 infection and vaccination are long-lasting, with an initial decline followed by stabilization after seven to nine months, highlighting the effectiveness of mRNA vaccines and the importance of hybrid immunity.

New-york , United-states , Paris , France-general- , France , America , Kateryna-kon , Protection-associated , Rapid-immunity , Antibodies , Oronavirus-disease-covid-19 , Ars

How did COVID-19 impact cancer incidence trends in the US?

Cancer rate patterns from March to December 2020.

Nevada , United-states , Indiana , District-of-columbia , International-classification-of-diseases , World-health-organization , United-states-preventive-services-task , Undiagnosed-cancer-cases , Image-credit , Image-point , States-cancer-statistics

COVID-19's neurological effects linked to immune response, not direct viral attack

Study identifies neurocognitive symptoms in COVID-19 patients as a reaction to systemic infection rather than direct brain infection, highlighting changes in the brain's immune response and synaptic organization.

Rattiya-thongdumhyu , Nature-neuroscience , Brain , Oronavirus-disease-covid-19 , Lood , Rain-fog , Ell , Entral-nervous-system , Oronavirus , Atigue , Enes

Cirrhosis patients face mixed infection outcomes amid pandemic healthcare shifts

The COVID-19 pandemic's influence on healthcare systems led to mixed outcomes for patients with cirrhosis, showing stable infection rates but a rise in multi-drug resistant organism (MDRO) infections.

Gorodenkoff-shutterstock , Scientific-reports , Cirrhosis , Oronavirus-disease-covid-19 , Andemic , Ntibiotic , Ntibiotic-resistance , Hronic , Oronavirus , Ealthcare , Mmune-system

Maternal COVID-19 vaccination equally benefits preterm and full-term babies

A study in JAMA Network Open reveals that maternal COVID-19 vaccination provides similar antibody levels in preterm and full-term infants' cord blood, with higher doses leading to increased antibodies.

Sciepro-shutterstock , Antibody-concentrations , Infants-born , Image-credit , Antibody , Oronavirus-disease-covid-19 , Accine , Ntibodies , Aby , Lood , Oronavirus

Innovative COVID-19 test prototype uses bioluminescence for speedier results

Researchers used a luciferase-independent luminescence test to investigate whether the wild-type SARS-CoV-2 spike protein possesses pseudo-luciferase activity for Cypridina luciferin.

Myriamb-shutterstock , Autodock-vina , Pseudo-luciferase-activity , Image-credit , Bioluminescence , Oronavirus-disease-covid-19 , Ovid-19 , Lbumin , Ssay , Oronavirus , Lisa

COVID-19 vaccines show moderate success in preventing long COVID in kids

Study reveals that COVID-19 vaccines moderately reduce the risk of long COVID in children, with higher effectiveness observed in adolescents compared to younger children.

Initiative-pcornet-program , National-institutes-of-health , National-institutes , Enhance-recovery , Children , Oronavirus-disease-covid-19 , Fficacy , Dolescents , Rain , Rain-fog , Oronavirus

Study reveals intestinal helminth infection diminishes T cell response to COVID-19 mRNA vaccine

Study investigates the impact of helminth infection on COVID-19 mRNA vaccine efficacy, revealing that while antibody responses remain largely unaffected, T-cell responses are significantly impaired, particularly against Omicron variants.

Heligmosomoidespolygyrusbakeri-hpb , Cell , Oronavirus-disease-covid-19 , Accine , Ntibodies , Ntibody , D4 , Hildren , Oronavirus , Fficacy , Elminths

Study shows slight increase in Guillain-Barre syndrome risk with adenovirus COVID vaccines

Study investigates the link between COVID-19 vaccines and autoimmune/neurological diseases, focusing on Guillain-Barre syndrome (GBS) risks associated with adenovirus vector vaccines.

Kerala , India , Germany , United-kingdom , United-states , Mexico , France , German , Tirachard-kumtanom , Pfizer , Uk-national-immunoglobulin-database , Neuroimmunological-disease

mRNA COVID-19 vaccines highly effective in preventing hospitalizations among adolescents in Nordic study

Study evaluated the effectiveness of mRNA COVID-19 vaccines (BNT162b2, mRNA-1273, and heterologous schedules) in preventing hospitalization among adolescents in Nordic countries, finding high protection rates of 73% to 86% at six months.

Sweden , Finland , Denmark , Norway , Effectiveness-among , Image-credit , Adolescents , Oronavirus-disease-covid-19 , Oronavirus , Omologous , Micron